Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

LEARN ABOUT VGM

VGM Respiratory

Full Menu Search

The Tipping Point of Respiratory Outcomes in the Home

Published in Respiratory & Sleep on September 01, 2021

VGM's Dave Lyman talks with CEO of Encore Health Care, Zach Gantt, about the importance of respiratory outcomes in the DME world and how Encore can help manage patients, not devices. They also talk about building out individual care plans, managing populations of patients, and partnering with hospitals.

Learn more at www.encorehc.com.

Listen below or click here.

TAGS

From Our Experts

Telling the Patient's Story Through NIV Documentation thumbnail

Telling the Patient's Story Through NIV Documentation Under CMS's new policy, NIV documentation requires more than a diagnosis. Learn key strategies for medical necessity, compliance, and reimbursement.

Turning Unmet OSA Need Into Measurable Referral Growth thumbnail

Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes.

Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail

Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth.

VGM & Trace Medical Expand Respiratory, Biomedical & Dialysis Rentals thumbnail

VGM & Trace Medical Expand Respiratory, Biomedical & Dialysis Rentals VGM and Trace Medical execute an exclusive agreement, giving HME providers nationwide access to respiratory rentals, biomedical services, and dialysis rentals.

Simplify Your Reimbursement Process for the AffloVest thumbnail

Simplify Your Reimbursement Process for the AffloVest To support clinicians, care teams, and payer partners, Tactile Medical has streamlined the process for determining medical necessity and documentation standards for the AffloVest.

Alternative Sleep Therapies: Guidance for DME Providers thumbnail

Alternative Sleep Therapies: Guidance for DME Providers Discover how oral appliance therapy, eXciteOSA, and other alternative sleep therapies are reshaping care in 2026.

Introducing the F&P Nova Nasal in the United States thumbnail

Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea.

Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard thumbnail

Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard Discover how integrated sleep programs help providers cut OSA screening-to-treatment timelines to 30 days while improving patient outcomes.

Be Part of Something Bigger

Become a Member